BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Isarna Therapeutics

Isarna Therapeutics logo

Founded
1998
Patents
10
Clinical Trials
4
Publications
8

Technologies

Antisense Oligonucleotides

Isarna Therapeutics has an unmatched commitment to developing TGF-B inhibitors that stimulate the human immune system to effectively fight cancer. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.

Become a Member to view additional information about this company

Posts Mentioning This Company